Fierce Pharma August 22, 2023
By Fraiser Kansteiner

The “fundamental problem” with drug shortages, to hear FDA Commissioner Robert Califf tell it, is that “we essentially have two drug industries in the U.S.” (Matthew MacRoberts/FDA)

Robert Califf, M.D., is “fired up” about the spate of U.S. drug shortages that now constitutes a “national security threat,” the FDA commissioner said Tuesday.

“I did not come back to FDA to spend all my time on supply chain, but that’s what’s happened,” Califf said in response to a question about shortages during a recent presentation of the Alliance for a Stronger FDA. “And I feel like I know a lot about it, and I’m pretty fired up to do something about it.”

Countless therapeutics, from ADHD meds and...

Today's Sponsors

Venturous
Got healthcare questions? Just ask Transcarent

Today's Sponsor

Venturous

 
Topics: Biotechnology, FDA, Govt Agencies, Pharma, Pharma / Biotech
GPUs go biological: BBB unveils Bionode, lab-grown, living neuron compute for AI applications
The Download: speaking to robots, and growing pharmaceutical mushrooms
Sofinnova closes new fund and backs a trio of new biotechs
AstraZeneca's $1 Billion Deal Highlights Growing Interest in In Vivo Cell Therapies
Pharmacy Benefit Manager Reform Keeps Getting Scuttled, Despite Bipartisan Support

Share This Article